111 related articles for article (PubMed ID: 23259994)
21. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
[TBL] [Abstract][Full Text] [Related]
23. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
[TBL] [Abstract][Full Text] [Related]
24. Cimetidine enhances the antiproliferative effect of 5-fluorouracil on colon carcinoma SW620.
Komatsubara M; Nagata T; Miyauchi S; Kamo N
Anticancer Res; 1999; 19(2A):1153-7. PubMed ID: 10368668
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
26. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
[TBL] [Abstract][Full Text] [Related]
27. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling.
Schmidt WM; Kalipciyan M; Dornstauder E; Rizovski B; Steger GG; Sedivy R; Mueller MW; Mader RM
Int J Cancer; 2004 Nov; 112(2):200-12. PubMed ID: 15352031
[TBL] [Abstract][Full Text] [Related]
28. TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation.
Kwon OH; Kim JH; Kim SY; Kim YS
Int J Oncol; 2014 Feb; 44(2):583-90. PubMed ID: 24337061
[TBL] [Abstract][Full Text] [Related]
29. GRP78 Regulates Apoptosis, Cell Survival and Proliferation in 5-Fluorouracil-resistant SNUC5 Colon Cancer Cells.
Lee JH; Yoon YM; Lee SH
Anticancer Res; 2017 Sep; 37(9):4943-4951. PubMed ID: 28870916
[TBL] [Abstract][Full Text] [Related]
30. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
[TBL] [Abstract][Full Text] [Related]
31. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
32. Extracellular chaperonin 10 augments apoptotic cell death induced by 5-fluorouracil in human colon cancer cells.
Kim K; Yeo SG
Tumori; 2014; 100(6):e230-5. PubMed ID: 25688504
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of drug resistance.
Mader RM; Schmidt WM; Steger GG; Krupitza G
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):49-50. PubMed ID: 19203537
[No Abstract] [Full Text] [Related]
34. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.
Russo A; Maiolino S; Pagliara V; Ungaro F; Tatangelo F; Leone A; Scalia G; Budillon A; Quaglia F; Russo G
Oncotarget; 2016 Nov; 7(48):79670-79687. PubMed ID: 27835895
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
37. Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil.
Wang S; El-Deiry WS
Cancer Res; 2004 Sep; 64(18):6666-72. PubMed ID: 15374982
[TBL] [Abstract][Full Text] [Related]
38. Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.
Ravizza R; Molteni R; Gariboldi MB; Marras E; Perletti G; Monti E
Eur J Cancer; 2009 Mar; 45(5):890-8. PubMed ID: 19171477
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU.
Hatata T; Higaki K; Tatebe S; Shomori K; Ikeguchi M
Dis Esophagus; 2012; 25(8):716-22. PubMed ID: 22292507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
